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The first implementation and use of an in situ size exclusion chromatography
(SEC) system on a small-angle neutron scattering instrument (SANS) is
described. The possibility of deploying such a system for biological solution
scattering at the Institut Laue–Langevin (ILL) has arisen from the fact that
current day SANS instruments at ILL now allow datasets to be acquired using
small sample volumes with exposure times that are often shorter than a minute.
This capability is of particular importance for the study of unstable biological
macromolecules where aggregation or denaturation issues are a major problem.
The first use of SEC-SANS on ILL’s instrument D22 is described for a variety of
proteins including one particularly aggregation-prone system.
1. Introduction
Small-angle scattering (SAS) is a powerful technique that can
yield important low-resolution structural information on
macromolecular systems. The X-ray and neutron scattering
analogues of the technique (SAXS and SANS, respectively)
are strongly complementary and provide different structural
information. SAXS methods have become increasingly widely
used at synchrotron radiation (SR) sources, often supporting
structural information from crystallography, electron micro-
scopy and NMR (Appolaire et al., 2015; Delaforge et al., 2015;
Hennig et al., 2014; Lapinaite et al., 2013). SAXS studies
typically provide overall ‘envelope’ information on protein
structure, and the high fluxes available at SR sources may be
exploited in parametric studies. SANS methods provide the
same type of information but – crucially – offer the ability to
use solvent contrast variation to distinguish and model
different parts of a multi-component system, either through
the availability of natural contrast (e.g. nucleic acid/protein
complexes) or by selective deuteration (e.g. protein–protein
complexes). SANS data collection is also effectively free of the
effects of radiation damage – something that is often a major
problem in SAXS work. The growth in the use of SAXS
methods by structural biologists over the past 20 years or so
has occurred as a result of developments in instrumentation at
SR sources, as well as the availability of user-friendly analysis
software. There has also been greatly increased use of SANS
methods in structural biology in the recent past, with major
developments in detector technology, beamline fluxes and
sample provision having a strong impact on the uptake of the
technique. The high demand for SAS capabilities has meant
that a number of central facilities operate dedicated instru-
ments for biological SAXS (Pernot et al., 2013; Tsutakawa et
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al., 2007; Tsuruta et al., 1998) and SANS (Heller et al., 2014).
These accommodate efficient sample managing systems that
allow high-throughput data collection (Round et al., 2015;
Martel et al., 2012; Hura et al., 2009). One of the more recent
developments for SAXS has been the availability of in situ size
exclusion chromatography (David & Pe´rez, 2009; Round et al.,
2013) (SEC), which allows SAXS data to be collected from
freshly purified sample material.
In this paper we describe the first SANS measurements
carried out in combination with an in situ SEC system on
instrument D22 at the Institut Laue–Langevin (ILL). This
development has only been possible because the high neutron
flux on this instrument allows short exposure times on rela-
tively small sample volumes. The new system allows data
quality to be significantly improved, particularly for difficult
aggregation-prone systems.
2. Materials and methods
2.1. Sample preparation
Gel filtration standards were purchased from BioRad,
reference 151-190. This contained 5 mg of bovine thyro-
globulin (670 kDa), 5 mg of bovine -globulin (158 kDa),
5 mg of chicken ovalbumin (44 kDa), 2.5 mg of horse
myoglobin (17 kDa) and 0.5 mg of vitamin B (1.35 kDa). Each
standard mixture is diluted in its elution buffer. The proto-
nated and deuterated proteins Sir2a (34 kDa) and Alba3
(13 kDa) were prepared at the Deuteration Laboratory in the
Life Sciences Group of ILL (Haertlein et al., 2016) according
to the protocols given below.
For recombinant protein expression of Sir2a and Alba3,
pET-28a Sir2a and Alba3, clones were obtained by cloning
into the pET-28a plasmid two codon-optimized gene
sequences optimized from the Plasmodium falciparum Sir2a
(Zhu et al., 2012) and Alba3 genes (PF3D7_1328800 and
PF3D7_1006200). These clones were transformed into the
Escherichia coli BL21 DE3 strain. Bacterial cultures were
grown in lysogeny broth medium at 310 K until an optical
density at 600 nm wavelength (OD600) of 0.6–0.8 was reached.
Both sets of cultures were induced with 1 mM isopropyl -d-1-
thiogalactopyranoside (IPTG) and grown for a further 3 h at
310 K and 20 h at 293 K for Sir2a and Alba3, respectively.
Cells were harvested by centrifugation and stored at 193 K
prior to lysis.
For deuterated Alba3 production, bacterial cultures were
adapted to growth in 85% deuterated minimal media prior to
inoculation of 1.5 l of fermentation culture. The fermenter
culture was allowed to reach an OD600 of 17.0 before induction
with 1 mM IPTG at 298 K. The culture was grown to a final
OD600 of 21 after 23 h. Cells were harvested by centrifugation
and stored at 193 K.
For purification, Sir2a frozen cell pellets were re-suspended
on ice in lysis buffer (25 mM Tris, 300 mM sodium chloride,
2 mM imidazole pH 7.5) supplemented with benzonase
nuclease and EDTA free protease inhibitor cocktail (Roche)
and lysed by passing cells through a cell-disruptor three times.
The cell lysates were centrifuged at 20 000 r min1 for 30 min
at 277 K and loaded onto a GE HiTrap TALON column using
a 1 ml min1 flow rate at 277 K. The column was washed with
wash buffer (25 mM Tris, 300 mM sodium chloride, 20 mM
imidazole pH 7.5) and protein eluted in 25 mM Tris, 300 mM
sodium chloride, 300 mM imidazole pH 7.5.
Protonated and deuterated Alba3 cell pellets were re-
suspended on ice in lysis buffer (50 mM sodium phosphate,
500 mM sodium chloride, 10 mM imidazole pH 7.0) supple-
mented with benzonase nuclease and EDTA free protease
inhibitor cocktail and were lysed by sonication using a Sonics
Vibra cell VC750 sonicator (10 s on, 59 s off, 10 cycles 50%
amplitude). The cell lysates were centrifuged at 20 000 r min1
for 30 min at 277 K and loaded onto a GE HisTrap Ni-NTA
column using a 5 ml min1 flow rate at 277 K. The column was
washed with a solution of 50 mM sodium phosphate, 1M
sodium chloride, 40 mM imidazole pH 7.0, and protein eluted
in 50 mM sodium phosphate, 500 mM sodium chloride,
500 mM imidazole pH 7.0.
Proteins were concentrated using Millipore 10 and 3 kDa
centrifugal filtration units for Sir2a and Alba3 respectively,
before gel filtration either on the SANS instrument or in a
cold room right before the SANS measurement.
2.2. SANS data recording and reduction
SANS data were recorded on diffractometers D11 (static
measurement of freshly purified sample) and D22 (in situ
chromatography) of ILL. The in situ size exclusion chroma-
tography was performed using an AKTAPrime system (GE
Healthcare) with a Superdex 75 Column 10/300 GL. The
samples were manually injected and then sequentially passed
through the size exclusion column, the spectrophotometer
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Figure 1
Setup of in situ chromatography SANS. The sample is manually injected
into the loop (1), then it passes through the size exclusion column (2), the
SANS sample cell (3), the UV–visible spectrophotometer (4) and the
valve (5), which directs it either to the fraction collector (6) or to the
waste container (60).
measurement cell and the SANS measurement cell before
being collected in a fraction collector (Fig. 1). The flow rate
was maintained at 0.3 ml min1 throughout data collection.
2.3. SANS instrument configurations
SEC-SANS measurements on instrument D22 were carried
out using a neutron wavelength of 6 A˚  10%, detector
distances of 8, 4 or 2 m, a rectangular collimation system of
55  40 mm having the same length as the sample–detector
distance, and a rectangular sample aperture of 7 10 mm. The
sample holder was a Suprasil quartz cell of 1 mm sample
thickness placed in the ‘stopped-flow head’ (Grillo, 2009). The
exposure time was 30 s. Sample injection started at the same
time as SANS data acquisition. The whole setup was main-
tained at a temperature of 288 K.
In both experiments, the data were reduced using the
GRASP software (https://www.ill.eu/instruments-support/
instruments-groups/groups/lss/grasp/home/) and analyzed
using Igor NCNR SANS reduction macros (Kline, 2006). The
corrections applied included subtraction of the blocked beam
and the empty cell scattering, transmission and thickness
scaling, absolute intensity calibration using the direct beam
intensity, and buffer subtraction. For SEC-SANS, the trans-
mission of the buffer, recorded during elution of the column
dead volume, was used for scaling the
protein signal. Short exposures were
averaged, after normalization for
sample concentration, to increase the
signal-to-noise ratio as necessary.
3. Results
3.1. Proof of concept: calibration
standards
Size exclusion chromatography
standards for calibration were used to
test and calibrate the in situ chroma-
tography system on D22 while
measuring the SANS signal in the 8 m
configuration. One 18 mg vial of protein, resuspended in
0.5 ml of buffer, was used per gel filtration, leading to a total
concentration of 36 mg ml1. The averaged absolute intensity
at aQ range of 0.007Q 0.02 A˚1 is plotted as a function of
time in Fig. 2, together with the UV absorbance at 280 nm,
which was measured at a point between the SANS measure-
ment cell and the fraction collector. This experiment was
repeated twice: once by eluting the sample with an H2O buffer
(Fig. 2a) and once with a D2O buffer (Fig. 2b). The columns
enabled good separation of ovalbumin (44 kDa) and
myoglobin (17 kDa), while thyroglobulin and -globulin
eluted in the excluded volume (first peak). Vitamin B12 was
visible on the UVabsorbance plot but the signal was too small
to be analyzed by SANS.
The stagger of these plots reflects the time taken for the
sample to travel from the SANS measurement cell to the UV
absorbance measurement cell and has to be accounted for in
concentration normalization. The UV absorbance profile
shows that the separated proteins do not re-mix significantly
following their passage through the relatively large SANS
measurement cell. Even protonated protein in an H2O buffer
(the worst combination in terms of the contribution to data
from hydrogen incoherent scattering) can be successfully
subjected to a SEC-SANS analysis. Data recorded during the
gel filtration in D2O buffer were submitted to a Guinier
analysis using the GRASP software,
and the results are compared with
literature data in Table 1. Three expo-
sures of 30 s each, taken symmetrically
from the top of the peak, were aver-
aged to build the myoglobin SANS
curve. Five were taken for ovalbumin
and ten for the buffer. The corre-
sponding values of absorbance at
280 nm, extracted from the chromato-
gram, were averaged for the estimation
of concentration using the Beer–
Lambert method. The experimental
values of Rg are consistent with those in
the literature for both proteins (Gold-
enberg & Argyle, 2014; Fujisawa &
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Figure 2
SEC-SANS measurements of SEC calibration standards eluted with 0% (a) and 100% (b) D2O
buffer. The absorbance of the sample at 280 nm is plotted in blue, and the averaged SANS intensity
between Q = 0.007 A˚1 and Q = 0.02 A˚1 is in red. The column (Superdex 75) efficiently separates
proteins of molecular weight (MW) from 3000 to 70000 Da.
Table 1
Experimental (fitted using GRASP) structural parameters derived from the results of in situ SEC-
SANS analysis of the BioRAD calibration standard in 100% D2O buffer.
MW: molecular weight; Extinc. coef.: extinction coefficient; Abs.: absorbance; I(Q=0): scattering intensity
extrapolated at Q = 0; Rg: radius of gyration. For comparison, literature data are extracted from references
1: Ianeselli et al. (2010a,b); 2: Doster et al. (2003); 3: Goldenberg & Argyle (2014); 4: Fujisawa & Kato
(2002).









(cm1) Rg (A˚) Rg (A˚)
Ovalbumin 44000 0.7 0.272 0.142  0.001 24.0  0.4 23–241
Myoglobin 17000 0.82 0.433 0.0401  0.0005 14.0  0.4 14.8  0.22
13.93
17.5  0.14
Kato, 2002; Ianeselli et al., 2010a,b;
Doster et al., 2003).
3.2. Feasibility: example of a clas-
sical case
Alba3 is a small aggregation-
prone protein of 13 kDa. It is used
here in its protonated form and at a
concentration of 0.9 mg ml1 to
represent a typical case for Bio-
SANS experiments. The protein was
stocked in an H2O buffer and eluted
either with an H2O buffer or a D2O
buffer. Fig. 3 shows the two resulting
elution profiles as well as the indi-
vidual SANS curves (30 s exposure)
taken from the top of the two
elution peaks. As above, the delay
between the SANS intensity peak
and the UV absorbance peak corre-
sponds to the travel of the protein
between the two measurement cells.
The UVabsorbance, by elution with
both buffers, shows three peaks: the
first corresponds to some aggregates,
the second to the Alba3 monomer,
and the third, low-intensity one
probably corresponds to traces of
imidazole used in the purification
protocol that do not produce any
coherent neutron scattering owing
to the small size of the molecule and
the low concentration. The SANS
intensity profile obtained by elution
with H2O buffer shows two peaks;
by contrast, elution with D2O buffer
results in a third peak of high
intensity. This peak, which the
SANS curve reveals to be essentially
incoherent scattering, is attributed
to the H2O buffer injected with the
protein and eluting at the very end
of the column. The separation of this
peak suggests an efficient buffer
exchange. The plots of the individual
SANS curves (30 s exposures) illus-
trate the data quality obtained in
each case. As expected, the quality
of the data is much better in the case
of elution with D2O buffer.
However, interestingly, even data
recorded at low contrast (elution
with H2O buffer) and low concen-
tration are suitable for Guinier
analysis, showing that SEC-SANS is
feasible with rather diluted samples.
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Figure 3
Results of the SEC-SANS measurement of protonated Alba3 in 0% (a) and 100% (b) D2O buffer,
showing the absorbance of the sample at 280 nm in blue and the averaged SANS intensity between Q =
0.012 A˚1 andQ = 0.041 A˚1 in red. (c) and (d) show individual SANS curves (30 s exposures) recorded
during elution in 0 and 100%D2O buffer, respectively, from the top of the first (open circles) and second
(full circles) peaks. The Rg values are obtained using the AutoRg function from primus (Konarev et al.,
2003).
Figure 4
(a) Results of the SEC-SANS measurement of protonated Sir2a (4 mg ml1) in 100% D2O buffer,
showing the absorbance of the sample at 280 nm (in blue) and the averaged SANS intensity betweenQ =
0.012 A˚1 and Q = 0.041 A˚1 (in red). (b) Magnified plot of SANS intensity of the Sir2A elution peak.
The large symbols show the three individual positions, selected at the beginning (open circle, Rg = 35.1
1.6 A˚), the top (black circle, Rg = 30.3 1.1 A˚) and the end (gray circle, Rg = 31.7 1.3 A˚) of the elution
peak, from which are extracted individual SANS curves (c) (30 s exposure) and the Guinier plot (d) (the
red lines being the fits of the Guinier region).
3.3. Specific benefits: example of a sensitive case
SANS studies are very sensitive to the presence of aggre-
gates or oligomers in the sample. Moreover, the ab initio
modeling of the molecule in question is only valid on the basis
of sample monodispersity and an absence of inter-particle
interactions (attractive or repulsive). Consequently, the
preparation of a sample optimized for SANS is a real chal-
lenge: the intrinsic instability of the molecule is often the main
obstacle for a viable analysis using SAS techniques (X-rays or
neutrons).
Sir2a is a very delicate protein and its measurement by
SANS using a conventional experimental setup led to unsa-
tisfactory results, with clear evidence of aggregation from a
Guinier analysis – even when the protein was measured
immediately (i.e. minutes) after normal SEC purification. This
protein therefore provided an excellent test of the SEC-SANS
system. Its elution profile is shown in Fig. 4. Figs. 4(a) and 4(b)
show an asymmetric elution peak in UVabsorbance as well as
in the averaged SANS intensity at small angle (0.012 < Q <
0.4 A˚1). The Guinier plots for the individual SANS curves
(Fig. 4c) selected at the beginning, the top and the end of the
elution peak are shown in Fig. 4(d) and demonstrate that the
extracted Rg varies significantly between curves. The asym-
metry in the absorbance peak, coupled with the decrease of Rg
along the elution peak and the fact that this Rg is larger than
the value calculated from the crystalline structure (24 A˚), is a
clear signature that the system is not monodisperse but rather
is composed of monomers and oligomers. Ultracentrifugation
measurements later confirmed the presence of trimers and
monomers. As we know the oligomeric state of all present
species, the SANS curve can then be fitted with the contri-
bution of model oligomers using the FoXS software
(Schneidman-Duhovny et al., 2010) or Oligomer from the
ATSAS suite (Konarev et al., 2003) to estimate the volume
fraction of each mixture component. Such an analysis will be
detailed in a later publication, together with results of analy-
tical ultracentrifugation.
4. Conclusion and future perspectives
The high neutron fluxes available on ILL SANS instruments,
combined with a low-background spectrometer (like D22),
enable the acquisition of high-quality data with short exposure
times. However, to fully exploit this flux to characterize
aggregation-prone biomacromolecules in solution, an online
size exclusion chromatography capability offers major
advantages for the study of difficult or complex systems.
The results clearly demonstrate the feasibility of the SEC-
SANS approach and that it brings real benefits to structural
studies of aggregation-prone biomolecules that could not be
measured in their monomeric state using a conventional
experimental arrangement. The Alba3 results show that the
SANS signal from the monomer can be separated from that of
its aggregates. The Sir2a system was a much more complicated
one, existing as an equilibrium between monomeric and
dimeric states; this was also successfully analyzed. To our
knowledge, this is the first time that such a combination of
SEC and SANS has been carried out. It should be noted that
care needs to be taken when designing a SEC-SANS experi-
ment: the contrast should be optimized through a judicious
choice of the deuteration of either the solvent or the molecule
of interest, or a combination of both. A sufficient concentra-
tion must be used (at least 1 mg ml1 for medium sized
proteins), but the molecules can be stored in an H2O buffer up
until the time of measurement since the SEC column is an
efficient means of buffer exchange. This property also enables
re-use of the same sample for multiple contrast measurements,
saving samples and freeing the interpretation from the
consequences of sample variability. In the case of a mixed
sample consisting of an equilibrium either between two
oligomerization states or between two configurations, the
SEC-SANS approach cannot separate the different states, but
it can provide an aggregate-free averaged SANS curve,
enabling an accurate estimation of the relative amount of each
state and hence modeling through a structural ensemble
approach (Bernado´ et al., 2007; Schneidman-Duhovny et al.,
2010).
The volume probed by the neutron beam, the exposure time
and the sample flow rate (70 ml, 30 s and 300 ml min1,
respectively, in this study) are the parameters defining the
resolution of the SEC-SANS approach and can be tailored to
a given study. Although the system is well matched to the
study of even rather challenging protein systems, the possi-
bility of very fast aggregation occurring between the exit from
the SEC column and the exit from the SANS measurement
cell cannot be ruled out.
Following this proof of concept, a dedicated chromato-
graphy system, integrated with the instrument hardware and
control software, will be implemented in order to tackle new
‘sensitive’ protein structures. Full integration of SEC with the
instrument data acquisition will enable us to reduce the flow
rate when the protein reaches the scattering measurement cell
in order to achieve better statistics (if needed) without
affecting the concentration and possible aggregation. In
addition, data recorded in streaming mode through the entire
sequence will allow finer and better data post processing.
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